Drug Type Cytokines |
Synonyms |
Target |
Action agonists |
Mechanism IL-2Rβγ agonists(Interleukin-2 Rβγ agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | China | 13 Dec 2024 | |
Colorectal Cancer | Phase 2 | United States | 13 Dec 2024 | |
Hepatocellular Carcinoma | Phase 2 | United States | 13 Dec 2024 | |
Hepatocellular Carcinoma | Phase 2 | China | 13 Dec 2024 | |
Melanoma | Phase 2 | China | 13 Dec 2024 | |
Melanoma | Phase 2 | United States | 13 Dec 2024 | |
Non-Small Cell Lung Cancer | Phase 2 | United States | 13 Dec 2024 | |
Ovarian Cancer | Phase 2 | China | 13 Dec 2024 | |
Ovarian Cancer | Phase 2 | United States | 13 Dec 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 2 | United States | 05 Jun 2024 |